MedTrace Logo

Evaluation of Prealbumin Levels in Men With Low-T

NCT03313635 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2018-07-13

No results posted yet for this study

Summary

This is a single-center study intended to evaluate prealbumin (transthyretin), a marker of anabolic metabolism, in men with androgen deficiency (Low-T). There is emerging evidence that prealbumin is an indicator of anabolic, versus catabolic, metabolism, and that lower levels may be associated with hypogonadism.

Conditions

  • Testosterone Deficiency

Interventions

DIAGNOSTIC_TEST

Men presenting with low-T

Evaluation of prealbumin levels.

Sponsors & Collaborators

  • Beckman Coulter, Inc.

    lead INDUSTRY

Principal Investigators

  • Abraham Morgentaler, MD · Men's Health Boston

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-08
Primary Completion
2017-12-31
Completion
2017-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03313635 on ClinicalTrials.gov